Cargando…
Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Response to Letter]
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111333/ https://www.ncbi.nlm.nih.gov/pubmed/33986611 http://dx.doi.org/10.2147/PGPM.S316851 |
| _version_ | 1783690478377500672 |
|---|---|
| author | Takahashi, Paul Y Ryu, Euijung Cerhan, James R Bielinski, Suzette J Olson, Janet E |
| author_facet | Takahashi, Paul Y Ryu, Euijung Cerhan, James R Bielinski, Suzette J Olson, Janet E |
| author_sort | Takahashi, Paul Y |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8111333 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Dove |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81113332021-05-12 Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Response to Letter] Takahashi, Paul Y Ryu, Euijung Cerhan, James R Bielinski, Suzette J Olson, Janet E Pharmgenomics Pers Med Response to Letter Dove 2021-05-06 /pmc/articles/PMC8111333/ /pubmed/33986611 http://dx.doi.org/10.2147/PGPM.S316851 Text en © 2021 Takahashi et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| spellingShingle | Response to Letter Takahashi, Paul Y Ryu, Euijung Cerhan, James R Bielinski, Suzette J Olson, Janet E Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Response to Letter] |
| title | Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Response to Letter] |
| title_full | Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Response to Letter] |
| title_fullStr | Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Response to Letter] |
| title_full_unstemmed | Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Response to Letter] |
| title_short | Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Response to Letter] |
| title_sort | pathway to ascertain the role of pharmacogenomics in healthcare utilization outcomes [response to letter] |
| topic | Response to Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111333/ https://www.ncbi.nlm.nih.gov/pubmed/33986611 http://dx.doi.org/10.2147/PGPM.S316851 |
| work_keys_str_mv | AT takahashipauly pathwaytoascertaintheroleofpharmacogenomicsinhealthcareutilizationoutcomesresponsetoletter AT ryueuijung pathwaytoascertaintheroleofpharmacogenomicsinhealthcareutilizationoutcomesresponsetoletter AT cerhanjamesr pathwaytoascertaintheroleofpharmacogenomicsinhealthcareutilizationoutcomesresponsetoletter AT bielinskisuzettej pathwaytoascertaintheroleofpharmacogenomicsinhealthcareutilizationoutcomesresponsetoletter AT olsonjanete pathwaytoascertaintheroleofpharmacogenomicsinhealthcareutilizationoutcomesresponsetoletter |